PUMA BIOTECHNOLOGY, INC. Investment Income, Interest
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Investment Income, Interest of $831.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. investment income, interest for the quarter ending 2026-06-30 was $831.00K, a 13.08% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for the quarter ending 2026-03-31 was $1.00M, a 8.99% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for the quarter ending 2025-12-31 was $977.00K, a 20.31% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for the quarter ending 2025-09-30 was $1.04M, a 18.56% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for fiscal 2025 was $4.08M, a 13.67% decline from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for fiscal 2024 was $4.72M, a 81.34% increase from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for fiscal 2023 was $2.60M, a 220.42% increase from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. investment income, interest for fiscal 2022 was $813.00K, a 408.13% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed | Investment Income, Interest 16 month | Investment Income, Interest 18 month | Investment Income, Interest 21 month | Investment Income, Interest 25 month | Investment Income, Interest 27 month | Investment Income, Interest 30 month | Investment Income, Interest 33 month | Investment Income, Interest 36 month | Investment Income, Interest 39 month | Investment Income, Interest 42 month | Investment Income, Interest 45 month | Investment Income, Interest 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $831.00K 10-Q · filed 2026-08-06 | $1.83M 10-Q · filed 2026-08-06 | $2.81M derived: sum of 3 quarters · filed 2026-08-06 | $3.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-07 | $1.98M derived: sum of 2 quarters · filed 2026-05-07 | $3.02M derived: sum of 3 quarters · filed 2026-05-07 | $3.98M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2025-12-31 | $977.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.02M derived: sum of 2 quarters · filed 2026-02-26 | $2.98M derived: sum of 3 quarters · filed 2026-08-06 | $4.08M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-06 | $2.00M derived: sum of 2 quarters · filed 2026-08-06 | $3.10M 10-Q · filed 2025-11-06 | $4.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2025-06-30 | $956.00K 10-Q · filed 2026-08-06 | $2.06M 10-Q · filed 2026-08-06 | $3.28M derived: sum of 3 quarters · filed 2026-08-06 | $4.57M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||||||
| 2025-03-31 | $1.10M 10-Q · filed 2026-05-07 | $2.33M derived: sum of 2 quarters · filed 2026-05-07 | $3.61M derived: sum of 3 quarters · filed 2026-05-07 | $4.85M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||||||
| 2024-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.51M derived: sum of 2 quarters · filed 2026-02-26 | $3.75M derived: sum of 3 quarters · filed 2026-02-26 | $4.72M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2024-09-30 | $1.28M 10-Q · filed 2025-11-06 | $2.53M derived: sum of 2 quarters · filed 2025-11-06 | $3.50M 10-Q · filed 2025-11-06 | $4.22M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2024-06-30 | $1.24M 10-Q · filed 2025-08-07 | $2.22M 10-Q · filed 2025-08-07 | $2.94M derived: sum of 3 quarters · filed 2026-02-26 | $3.62M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2024-03-31 | $972.00K 10-Q · filed 2025-05-08 | $1.69M derived: sum of 2 quarters · filed 2026-02-26 | $2.38M derived: sum of 3 quarters · filed 2026-02-26 | $3.04M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2023-12-31 | $719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.41M derived: sum of 2 quarters · filed 2026-02-26 | $2.07M derived: sum of 3 quarters · filed 2026-02-26 | $2.60M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2023-09-30 | $689.00K 10-Q · filed 2024-11-07 | $1.35M derived: sum of 2 quarters · filed 2024-11-07 | $1.89M 10-Q · filed 2024-11-07 | $2.40M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||||||
| 2023-06-30 | $660.00K 10-Q · filed 2024-08-01 | $1.20M 10-Q · filed 2024-08-01 | $1.72M derived: sum of 3 quarters · filed 2025-02-27 | $1.93M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||||||
| 2023-03-31 | $537.00K 10-Q · filed 2024-05-02 | $1.06M derived: sum of 2 quarters · filed 2025-02-27 | $1.27M derived: sum of 3 quarters · filed 2025-02-27 | $1.34M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||||||
| 2022-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $735.00K derived: sum of 2 quarters · filed 2025-02-27 | $800.00K derived: sum of 3 quarters · filed 2025-02-27 | $813.00K 10-K · filed 2025-02-27 | ||||||||||||||||
| 2022-09-30 | $216.00K 10-Q · filed 2023-11-02 | $281.00K derived: sum of 2 quarters · filed 2023-11-02 | $294.00K 10-Q · filed 2023-11-02 | $307.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||||
| 2022-06-30 | $65.00K 10-Q · filed 2023-08-03 | $78.00K 10-Q · filed 2023-08-03 | $91.00K derived: sum of 3 quarters · filed 2024-02-29 | $104.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||||
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-04 | $26.00K derived: sum of 2 quarters · filed 2024-02-29 | $39.00K derived: sum of 3 quarters · filed 2024-02-29 | $160.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||||
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $26.00K derived: sum of 2 quarters · filed 2024-02-29 | $147.00K derived: sum of 3 quarters · filed 2024-02-29 | $160.00K 10-K · filed 2024-02-29 | ||||||||||||||||
| 2021-09-30 | $13.00K 10-Q · filed 2022-11-03 | $134.00K derived: sum of 2 quarters · filed 2022-11-03 | $147.00K 10-Q · filed 2022-11-03 | $162.00K derived: sum of 4 quarters · filed 2023-03-02 | ||||||||||||||||
| 2021-06-30 | $121.00K 10-Q · filed 2022-08-04 | $134.00K 10-Q · filed 2022-08-04 | $149.00K derived: sum of 3 quarters · filed 2023-03-02 | $171.00K derived: sum of 4 quarters · filed 2023-03-02 | ||||||||||||||||
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-05 | $28.00K derived: sum of 2 quarters · filed 2023-03-02 | $50.00K derived: sum of 3 quarters · filed 2023-03-02 | $116.00K derived: sum of 4 quarters · filed 2023-03-02 | ||||||||||||||||
| 2020-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $37.00K derived: sum of 2 quarters · filed 2023-03-02 | $103.00K derived: sum of 3 quarters · filed 2023-03-02 | $489.00K 10-K · filed 2023-03-02 | ||||||||||||||||
| 2020-09-30 | $22.00K 10-Q · filed 2021-11-04 | $88.00K derived: sum of 2 quarters · filed 2021-11-04 | $474.00K 10-Q · filed 2021-11-04 | $972.00K derived: sum of 4 quarters · filed 2022-03-03 | ||||||||||||||||
| 2020-06-30 | $66.00K 10-Q · filed 2021-08-05 | $452.00K 10-Q · filed 2021-08-05 | $950.00K derived: sum of 3 quarters · filed 2022-03-03 | $1.52M derived: sum of 4 quarters · filed 2022-03-03 | ||||||||||||||||
| 2020-03-31 | $386.00K 10-Q · filed 2021-05-06 | $884.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.45M derived: sum of 3 quarters · filed 2022-03-03 | $2.36M derived: sum of 4 quarters · filed 2022-03-03 | ||||||||||||||||
| 2019-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.07M derived: sum of 2 quarters · filed 2022-03-03 | $1.98M derived: sum of 3 quarters · filed 2022-03-03 | $2.85M 10-K · filed 2022-03-03 | ||||||||||||||||
| 2019-09-30 | $569.00K 10-Q · filed 2020-11-05 | $1.48M derived: sum of 2 quarters · filed 2020-11-05 | $2.35M 10-Q · filed 2020-11-05 | $3.05M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||||
| 2019-06-30 | $908.00K 10-Q · filed 2020-08-06 | $1.78M 10-Q · filed 2020-08-06 | $2.48M derived: sum of 3 quarters · filed 2021-03-01 | $3.07M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||||
| 2019-03-31 | $872.00K 10-Q · filed 2020-05-07 | $1.57M derived: sum of 2 quarters · filed 2021-03-01 | $2.17M derived: sum of 3 quarters · filed 2021-03-01 | $2.49M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||||
| 2018-12-31 | $703.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.29M derived: sum of 2 quarters · filed 2021-03-01 | $1.62M derived: sum of 3 quarters · filed 2021-03-01 | $1.80M 10-K · filed 2021-03-01 | ||||||||||||||||
| 2018-09-30 | $590.00K 10-Q · filed 2019-11-07 | $919.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.09M 10-Q · filed 2019-11-07 | $1.31M derived: sum of 4 quarters · filed 2020-02-28 | ||||||||||||||||
| 2018-06-30 | $329.00K 10-Q · filed 2019-08-09 | $503.00K 10-Q · filed 2019-08-09 | $724.00K derived: sum of 3 quarters · filed 2020-02-28 | $1.03M derived: sum of 4 quarters · filed 2020-02-28 | ||||||||||||||||
| 2018-03-31 | $174.00K 10-Q · filed 2019-05-10 | $395.00K derived: sum of 2 quarters · filed 2020-02-28 | $700.00K derived: sum of 3 quarters · filed 2020-02-28 | $1.08M derived: sum of 4 quarters · filed 2020-02-28 | ||||||||||||||||
| 2017-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $526.00K derived: sum of 2 quarters · filed 2020-02-28 | $906.00K derived: sum of 3 quarters · filed 2020-02-28 | $1.26M 10-K · filed 2020-02-28 | ||||||||||||||||
| 2017-09-30 | $305.00K 10-Q · filed 2018-11-05 | $685.00K derived: sum of 2 quarters · filed 2018-11-05 | $1.03M 10-Q · filed 2018-11-05 | $1.24M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||||
| 2017-06-30 | $380.00K 10-Q · filed 2018-08-09 | $730.00K 10-Q · filed 2018-08-09 | $932.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.15M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||||
| 2017-03-31 | $350.00K 10-Q · filed 2018-05-10 | $552.00K derived: sum of 2 quarters · filed 2019-03-01 | $766.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.03M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||||
| 2016-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $416.00K derived: sum of 2 quarters · filed 2019-03-01 | $676.00K derived: sum of 3 quarters · filed 2019-03-01 | $958.00K 10-K · filed 2019-03-01 | ||||||||||||||||
| 2016-09-30 | $214.00K 10-Q · filed 2017-11-09 | $474.00K derived: sum of 2 quarters · filed 2017-11-09 | $756.00K 10-Q · filed 2017-11-09 | $1.07M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2016-06-30 | $260.00K 10-Q · filed 2017-08-09 | $542.00K 10-Q · filed 2017-08-09 | $859.00K derived: sum of 3 quarters · filed 2018-03-09 | $1.18M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2016-03-31 | $282.00K 10-Q · filed 2017-05-10 | $599.00K derived: sum of 2 quarters · filed 2018-03-09 | $917.00K derived: sum of 3 quarters · filed 2018-03-09 | $1.13M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2015-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $635.00K derived: sum of 2 quarters · filed 2018-03-09 | $848.00K derived: sum of 3 quarters · filed 2018-03-09 | $971.00K 10-K · filed 2018-03-09 | ||||||||||||||||
| 2015-09-30 | $318.00K 10-Q · filed 2016-11-09 | $531.00K derived: sum of 2 quarters · filed 2016-11-09 | $654.00K 10-Q · filed 2016-11-09 | $755.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2015-06-30 | $213.00K 10-Q · filed 2016-08-09 | $336.00K 10-Q · filed 2016-08-09 | $437.00K derived: sum of 3 quarters · filed 2017-03-01 | $548.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2015-03-31 | $123.00K 10-Q · filed 2016-05-10 | $224.00K derived: sum of 2 quarters · filed 2017-03-01 | $335.00K derived: sum of 3 quarters · filed 2017-03-01 | $401.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2014-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $212.00K derived: sum of 2 quarters · filed 2017-03-01 | $278.00K derived: sum of 3 quarters · filed 2017-03-01 | $324.00K 10-K · filed 2017-03-01 | ||||||||||||||||
| 2014-09-30 | $111.00K 10-Q · filed 2015-11-09 | $177.00K derived: sum of 2 quarters · filed 2015-11-09 | $223.00K 10-Q · filed 2015-11-09 | $267.00K derived: sum of 4 quarters · filed 2016-02-29 | $497.00K 10-Q · filed 2014-11-10 | |||||||||||||||
| 2014-06-30 | $66.00K 10-Q · filed 2015-08-10 | $112.00K 10-Q · filed 2015-08-10 | $156.00K derived: sum of 3 quarters · filed 2016-02-29 | $165.00K derived: sum of 4 quarters · filed 2016-02-29 | $386.00K 10-Q · filed 2014-08-11 | |||||||||||||||
| 2014-03-31 | $46.00K 10-Q · filed 2015-05-11 | $90.00K derived: sum of 2 quarters · filed 2016-02-29 | $99.00K derived: sum of 3 quarters · filed 2016-02-29 | $195.00K derived: sum of 4 quarters · filed 2016-02-29 | $320.00K 10-Q · filed 2014-05-12 | |||||||||||||||
| 2013-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $53.00K derived: sum of 2 quarters · filed 2016-02-29 | $149.00K derived: sum of 3 quarters · filed 2016-02-29 | $172.00K 10-K · filed 2016-02-29 | $274.00K 10-K · filed 2014-03-03 | |||||||||||||||
| 2013-09-30 | $9.00K 10-Q · filed 2014-11-10 | $105.00K derived: sum of 2 quarters · filed 2014-11-10 | $128.00K 10-Q · filed 2014-11-10 | $163.00K derived: sum of 4 quarters · filed 2015-03-02 | $230.00K 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $96.00K 10-Q · filed 2014-08-11 | $119.00K 10-Q · filed 2014-08-11 | $154.00K derived: sum of 3 quarters · filed 2015-03-02 | $168.00K derived: sum of 4 quarters · filed 2015-03-02 | $221.00K 10-Q · filed 2013-08-06 | |||||||||||||||
| 2013-03-31 | $23.00K 10-Q · filed 2014-05-12 | $58.00K derived: sum of 2 quarters · filed 2015-03-02 | $72.00K derived: sum of 3 quarters · filed 2015-03-02 | $95.00K derived: sum of 4 quarters · filed 2015-03-02 | $125.00K 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $49.00K derived: sum of 2 quarters · filed 2015-03-02 | $72.00K derived: sum of 3 quarters · filed 2015-03-02 | $98.00K 10-K · filed 2015-03-02 | $102.00K 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $14.00K 10-Q · filed 2013-11-12 | $14.44K 10-Q · filed 2012-11-14 | $37.00K derived: sum of 2 quarters · filed 2013-11-12 | $63.00K 10-Q · filed 2013-11-12 | $62.60K 10-Q · filed 2012-11-14 | $66.38K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $23.00K 10-Q · filed 2013-08-06 | $22.52K 10-Q · filed 2012-08-14 | $48.00K 10-Q · filed 2013-08-06 | $48.15K 10-Q · filed 2012-08-14 | $51.94K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2012-03-31 | $26.00K 10-Q · filed 2013-05-09 | $25.64K 10-Q · filed 2012-05-15 | $29.42K 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2011-12-31 | $4.00K 10-K · filed 2014-03-03 | $3.78K 10-K · filed 2012-03-29 | $3.78K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |